JF
SAGE

Jump Financial’s Sage Therapeutics SAGE Stock Holding History

Jump Financial’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-289,341
Closed -$2.64M – 2172
2025
Q2 		$2.64M Buy
289,341
+100,743
+53% +$741K 0.03% 631
2025
Q1 		$1.5M Buy
+188,598
New +$1.38M 0.02% 681
2024
Q4 		– Sell
-17,802
Closed -$129K – 1956
2024
Q3 		$129K Buy
17,802
+4,267
+32% +$39.1K ﹤0.01% 1509
2024
Q2 		$147K Sell
13,535
-16,387
-55% -$210K ﹤0.01% 1605
2024
Q1 		$561K Buy
29,922
+8,504
+40% +$196K 0.02% 1119
2023
Q4 		$464K Sell
21,418
-66,883
-76% -$1.33M 0.01% 1114
2023
Q3 		$1.82M Buy
+88,301
New +$2.55M 0.07% 409
2022
Q3 		– Sell
-6,745
Closed -$218K – 1916
2022
Q2 		$218K Buy
+6,745
New +$226K 0.01% 1252
2021
Q3 		– Sell
-3,800
Closed -$216K – 1453
2021
Q2 		$216K Buy
+3,800
New +$269K 0.02% 822

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Jump Financial's SAGE Position: Q3 2025 in Review

Jump Financial sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 289,341 shares — an estimated $2.64M sold.

Jump Financial first reported a position in SAGE in Q2 2021 and held it in 9 quarters. The position peaked at $2.64M in Q2 2025. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Jump Financial reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jump Financial sold 289,341 Sage Therapeutics shares in Q3 2025, an estimated $2.64M.
  • Jump Financial first reported a position in Sage Therapeutics in Q2 2021 and held it in 9 quarters.
  • Jump Financial's Sage Therapeutics position peaked at $2.64M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Jump Financial's 13F filing for Q3 2025, filed 13 Nov 2025.